Trial Profile
Suvorexant for the treatment of insomnia in patients with psychiatric disorders
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2019
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 25 May 2018 Status changed from recruiting to completed.
- 23 Nov 2016 New trial record